ReviewAdvances in rheumatology (London, England)2026
Position statement of the Biotechnology Committee of the Brazilian Society of Rheumatology on the interchangeability of originator and biosimilar biologics in immune-mediated rheumatic diseases.
Paulo Chicarone Pereira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.